| #89 |
Zheng Li |
MIT |
2 |
| #89 |
Christopher Fraser |
Selecta Biosciences |
2 |
| #89 |
Ellen DiResta |
Becton, Dickinson And |
2 |
| #89 |
Halong Vu |
Monsanto Technology |
2 |
| #89 |
Kevin Groves |
Visen Medical |
2 |
| #89 |
Paul Andrew Gray |
Indigo Ag |
2 |
| #89 |
Anna Gardberg |
Merck |
2 |
| #89 |
Liwei LI |
Manus Bio |
2 |
| #89 |
Michael Andrew Zalisk |
Bose |
2 |
| #89 |
Roger I. Khazan |
MIT |
2 |
| #89 |
Reeves Hoppe Briggs |
Microsoft |
2 |
| #89 |
Vasiliki Demas |
T2 Biosystems |
2 |
| #89 |
Evren Sirin |
Stardog Union |
2 |
| #89 |
I. Robert Silverman |
Concert Pharmaceuticals |
2 |
| #89 |
Sushil Shetty |
Schlumberger Technology |
2 |
| #89 |
Paul Bay |
Ab Initio Technology |
2 |
| #89 |
Wender Wang |
Thermacell Repellents |
2 |
| #89 |
Shyamala A. Subramanian |
E Ink Holdings |
2 |
| #89 |
Peter M. Musial |
Emc Ip Holding Company |
2 |
| #89 |
Kendra Marchant |
Emc Ip Holding Company |
2 |
| #89 |
Jeffrey H. Alexander |
Oracle |
2 |
| #172 |
Randy M. Fayan |
Avid Technology |
1 |
| #172 |
Daniel Robert Brownell |
Institute For Environmental Health |
1 |
| #172 |
Mark Marchionni |
Acorda Therapeutics |
1 |
| #172 |
Olivier Schueller |
Surface Logix |
1 |
| #172 |
Karen E. Thomas-Alyea |
A123 Systems |
1 |
| #172 |
Karen G. Carrasquillo |
Boston Foundation For Sight |
1 |
| #172 |
Alan Kwok |
Boston Foundation For Sight |
1 |
| #172 |
Tanya SHIRMAN |
Harvard University |
1 |
| #172 |
Kristine Homes Lewis |
— |
1 |
| #172 |
Youssef Barhomi |
Brown University |
1 |
| #172 |
Shawn S. Kuo |
Analog Devices |
1 |
| #172 |
Christophe Antczak |
Sloan Kettering Institute For Cancer Research |
1 |
| #172 |
Steven G. Johnson |
MIT |
1 |
| #172 |
Melanie Cooke |
Amgen |
1 |
| #172 |
Alexander Kordun |
IBM |
1 |
| #172 |
Paul Lyne |
Biogen Idec Ma |
1 |
| #172 |
Chandran V. Seshagiri |
— |
1 |
| #172 |
Katsuyuki Shiroguchi |
Harvard University |
1 |
| #172 |
Damon Weinstein |
Soundbite Communications |
1 |
| #172 |
Mary-Jane Lombardo McKenzie |
Seres Therapeutics |
1 |
| #172 |
Douglas Warren Young |
Bose |
1 |
| #172 |
Alkim Akyurtlu |
University Of Massachusetts |
1 |
| #172 |
Alice M. Chiang |
Teratech |
1 |
| #172 |
Sepand Ossia |
Schlumberger Technology |
1 |
| #172 |
Zhengzheng Pan |
Alkermes Pharma Ireland Limited |
1 |
| #172 |
Jakub Rybczynski |
Entegris |
1 |
| #172 |
Daniel Doty |
Draper Laboratory |
1 |
| #172 |
Oliver P. Peoples |
Metabolix |
1 |
| #172 |
Edwin Zargarian |
Arebus |
1 |